Crocetin regulates Th1/Th2 and Th17/Treg balances, nitric oxide production, and nuclear localization of NF‐κB in Th2‐provoked and normal situations in human‐isolated lymphocytes

Vafa Baradaran Rahimi,Saeideh Saadat,Pouria Rahmanian Devin,Ali Jebalbarezy,Maryam Moqaddam,Mohammad Hossein Boskabady,Vahid Reza Askari
DOI: https://doi.org/10.1002/biof.1942
2023-02-07
BioFactors
Abstract:The present work represented the immunomodulatory effects of crocetin on isolated lymphocytes of humans. Moreover, the results prove the promoting impacts of crocetin on T‐cell subsets toward Treg (IL‐) and Th1 (IFN‐γ). Thus, it can have therapeutic value for treating Th2 or Th17 cells predominant diseases including allergic disease and cancers, as well as inflammatory and autoimmune diseases like rheumatoid arthritis, multiple sclerosis, colitis, and psoriasis. Crocetin is a natural carotenoid dicarboxylic acid derived from Crocus sativus. It has been utilized as natural biomedicine with healing effects. The immunoregulatory and anti‐inflammatory properties may cause the biological activities of crocetin. Nevertheless, it is not still clear how this compound acts and causes an immune‐modulatory impact on human lymphocytes. The effects of three concentrations (5, 10, and 20 μM) of crocetin or dexamethasone (0.1 mM) were assessed on gene expression and secretion of cytokines, nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐κB) level, and nitric oxide (NO) production in phytohaemagglutinin (PHA)‐stimulated and non‐stimulated lymphocytes. By incubation with PHA, gene expression and cytokine concentration comprising interferon (IFN)‐γ, interleukin (IL)‐17A, IL‐10, and IL‐4 were increased, along with NF‐κB concentration and NO production (all, p
biochemistry & molecular biology,endocrinology & metabolism
What problem does this paper attempt to address?